Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 22

1.

The science behind hormone replacement therapy, part !

Wepfer ST.

Int J Pharm Compd. 2001 Nov-Dec;5(6):462-4. No abstract available.

PMID:
23982041
2.

Hormone replacement therapy: part 1 - the evolution of hormone treatment.

Lorentzen J.

Int J Pharm Compd. 2001 Sep-Oct;5(5):336-8. No abstract available.

PMID:
23981968
3.

Estrogen and progestogen use in postmenopausal women: 2010 position statement of The North American Menopause Society.

North American Menopause Society..

Menopause. 2010 Mar;17(2):242-55. doi: 10.1097/gme.0b013e3181d0f6b9.

PMID:
20154637
4.

A double-blind placebo-controlled study to evaluate the effect of progestelle progesterone cream on postmenopausal women.

Benster B, Carey A, Wadsworth F, Vashisht A, Domoney C, Studd J.

Menopause Int. 2009 Jun;15(2):63-9. doi: 10.1258/mi.2009.009014.

PMID:
19465671
6.
7.

Unequal risks for breast cancer associated with different hormone replacement therapies: results from the E3N cohort study.

Fournier A, Berrino F, Clavel-Chapelon F.

Breast Cancer Res Treat. 2008 Jan;107(1):103-11. Erratum in: Breast Cancer Res Treat. 2008 Jan;107(2):307-8.

8.

Low dose of transdermal estradiol gel for treatment of symptomatic postmenopausal women: a randomized controlled trial.

Simon JA, Bouchard C, Waldbaum A, Utian W, Zborowski J, Snabes MC.

Obstet Gynecol. 2007 Mar;109(3):588-96.

PMID:
17329509
9.

A study to look at hormonal absorption of progesterone cream used in conjunction with transdermal estrogen.

Vashisht A, Wadsworth F, Carey A, Carey B, Studd J.

Gynecol Endocrinol. 2005 Aug;21(2):101-5.

PMID:
16109596
10.
11.

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.

Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC, Kotchen JM, Ockene J; Writing Group for the Women's Health Initiative Investigators..

JAMA. 2002 Jul 17;288(3):321-33.

PMID:
12117397
12.

Estrogen in the prevention of atherosclerosis. A randomized, double-blind, placebo-controlled trial.

Hodis HN, Mack WJ, Lobo RA, Shoupe D, Sevanian A, Mahrer PR, Selzer RH, Liu Cr CR, Liu Ch CH, Azen SP; Estrogen in the Prevention of Atherosclerosis Trial Research Group..

Ann Intern Med. 2001 Dec 4;135(11):939-53.

PMID:
11730394
13.
14.

Safety and efficacy of oestriol for symptoms of natural or surgically induced menopause.

Takahashi K, Okada M, Ozaki T, Kurioka H, Manabe A, Kanasaki H, Miyazaki K.

Hum Reprod. 2000 May;15(5):1028-36.

15.

Initial 17beta-estradiol dose for treating vasomotor symptoms.

Notelovitz M, Lenihan JP, McDermott M, Kerber IJ, Nanavati N, Arce J.

Obstet Gynecol. 2000 May;95(5):726-31.

PMID:
10775738
16.

Transdermal progesterone cream for vasomotor symptoms and postmenopausal bone loss.

Leonetti HB, Longo S, Anasti JN.

Obstet Gynecol. 1999 Aug;94(2):225-8.

PMID:
10432132
17.

Estradiol therapy combined with progesterone and endothelium-dependent vasodilation in postmenopausal women.

Gerhard M, Walsh BW, Tawakol A, Haley EA, Creager SJ, Seely EW, Ganz P, Creager MA.

Circulation. 1998 Sep 22;98(12):1158-63.

18.
19.

Estradiol and progesterone regulate the proliferation of human breast epithelial cells.

Foidart JM, Colin C, Denoo X, Desreux J, Béliard A, Fournier S, de Lignières B.

Fertil Steril. 1998 May;69(5):963-9.

PMID:
9591509
20.

Influences of percutaneous administration of estradiol and progesterone on human breast epithelial cell cycle in vivo.

Chang KJ, Lee TT, Linares-Cruz G, Fournier S, de Ligniéres B.

Fertil Steril. 1995 Apr;63(4):785-91.

PMID:
7890063
Items per page

Supplemental Content

Support Center